U.S Physical Therapy Net Income 2010-2024 | USPH

U.S Physical Therapy net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
U.S Physical Therapy Annual Net Income
(Millions of US $)
2023 $28
2022 $32
2021 $41
2020 $35
2019 $40
2018 $35
2017 $22
2016 $21
2015 $21
2014 $19
2013 $13
2012 $18
2011 $21
2010 $16
2009 $12
U.S Physical Therapy Quarterly Net Income
(Millions of US $)
2024-09-30 $7
2024-06-30 $7
2024-03-31 $8
2023-12-31 $3
2023-09-30 $9
2023-06-30 $9
2023-03-31 $7
2022-12-31 $3
2022-09-30 $10
2022-06-30 $11
2022-03-31 $9
2021-12-31 $10
2021-09-30 $10
2021-06-30 $12
2021-03-31 $8
2020-12-31 $13
2020-09-30 $11
2020-06-30 $10
2020-03-31 $1
2019-12-31 $8
2019-09-30 $9
2019-06-30 $15
2019-03-31 $8
2018-12-31 $10
2018-09-30 $8
2018-06-30 $9
2018-03-31 $7
2017-12-31 $7
2017-09-30 $5
2017-06-30 $5
2017-03-31 $5
2016-12-31 $5
2016-09-30 $5
2016-06-30 $6
2016-03-31 $4
2015-12-31 $5
2015-09-30 $6
2015-06-30 $6
2015-03-31 $4
2014-12-31 $3
2014-09-30 $5
2014-06-30 $6
2014-03-31 $4
2013-12-31 $4
2013-09-30 $0
2013-06-30 $5
2013-03-31 $4
2012-12-31 $4
2012-09-30 $5
2012-06-30 $5
2012-03-31 $4
2011-12-31 $8
2011-09-30 $4
2011-06-30 $5
2011-03-31 $4
2010-12-31 $4
2010-09-30 $4
2010-06-30 $4
2010-03-31 $3
2009-12-31 $2
2009-09-30 $3
2009-06-30 $4
2009-03-31 $3
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.464B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.921B 12.66
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00